Louis Moore Bacon's TEVA Position Overview
Louis Moore Bacon (via Moore Capital Management, Lp) currently holds 165,197 shares of Teva Pharmaceutical Industries Limited (TEVA) worth $3.34 M, representing 0.05% of the portfolio. First purchased in 2014-Q4, this short-term holding has been held for 7 quarters.
Based on 13F filings, Louis Moore Bacon has maintained this position in TEVA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2020, adding 1.1 M shares. Largest reduction occurred in Q2 2020, reducing 1.1 M shares.
Analysis based on 13F filings available since 2013 Q2
Louis Moore Bacon's Teva Pharmaceutical Industries Limited (TEVA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Teva Pharmaceutical Industries Limited (TEVA) Trades by Louis Moore Bacon
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2014 | +180,000 | New Buy | 180,000 | $57.51 |
| Q1 2015 | -180,000 | Sold Out | 0 | $0.00 |
| Q4 2015 | +31,994 | New Buy | 31,994 | $65.64 |
| Q1 2016 | -31,994 | Sold Out | 0 | $0.00 |
| Q1 2020 | +1.1 M | New Buy | 1.1 M | $8.98 |
| Q2 2020 | -1.1 M | Sold Out | 0 | $0.00 |
| Q3 2025 | +165,197 | New Buy | 165,197 | $20.20 |
Louis Moore Bacon's Teva Pharmaceutical Industries Limited Investment FAQs
Louis Moore Bacon first purchased Teva Pharmaceutical Industries Limited (TEVA) in Q4 2014, acquiring 180,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon has held Teva Pharmaceutical Industries Limited (TEVA) for 7 quarters since Q4 2014.
Louis Moore Bacon's largest addition to Teva Pharmaceutical Industries Limited (TEVA) was in Q1 2020, adding 1,100,000 shares worth $9.88 M.
According to the latest 13F filing for Q3 2025, Louis Moore Bacon's firm, Moore Capital Management, Lp, owns 165,197 shares of Teva Pharmaceutical Industries Limited (TEVA), valued at approximately $3.34 M.
As of the Q3 2025 filing, Teva Pharmaceutical Industries Limited (TEVA) represents approximately 0.05% of Louis Moore Bacon's publicly disclosed stock portfolio, making it one of their key holdings.
Louis Moore Bacon's peak holding in Teva Pharmaceutical Industries Limited (TEVA) was 1,100,000 shares, as reported at the end of Q1 2020.